Nordic News, Business and Life in Asia
AstraZeneca announced that it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, a figure significantly lower than some investors had feared. The …
AstraZeneca reassures investors as China tax probe impact appears limited Read More
The Anglo-Swedish pharmaceutical giant AstraZeneca faces mounting pressure from shareholders regarding ongoing investigations in China, one of its key markets. The concerns emerged after the detention of Leon Wang, the …
Nordic investors seek clarity on AstraZeneca’s China investigations Read More
AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has experienced a significant decline in stock value, plummeting 15 percent over the past six months. This downturn follows alarming reports of a …
AstraZeneca faces challenges amid investigation and lawsuit Read More
AstraZeneca’s China president, Leon Wang, is now under investigation by Chinese authorities, the company announced in a press release. Earlier this fall, Bloomberg News reported that several current and former …
AstraZeneca’s China president under investigation Read More
Five AstraZeneca employees have been detained by Chinese police, according to Bloomberg News. The arrests are part of an investigation into the illegal import of cancer medication into China. AstraZeneca …
Several AstraZeneca employees arrested in China Read More
In an interview the British media Bloomberg interviews Pascal Soriot, CEO of AstraZeneca, expresses the importance of China for companies such as their own. When asked to explain why China …
AstraZeneca sees China as an important partner Read More
Anglo-Swedish drug company AstraZeneca announced that it signed a licensing agreement with Eccogene, a Chinese firm for oral medicines which will treat diabetes and obesity on Thursday, 9 November 2023. …
AstraZeneca signs agreement with Chinese firm for oral obesity drug Read More
The Anglo-Swedish pharma company, AstraZeneca’s Calquence product has been approved in China for the treatment of adults with leukemia. The company stated this on Monday, September 4. The product has …
AstraZeneca’s leukemia product approved in China Read More